Phase 2/3 Study of Effect of AT1RB Versus ACE Inhibitor in Addition to XO Inhibitor on Progression of LV Remodeling and Dysfunction in Diabetic Patients With Acute MI
Phase of Trial: Phase II/III
Latest Information Update: 05 Jun 2015
At a glance
- Drugs Candesartan cilexetil (Primary) ; Allopurinol; Ramipril
- Indications Hypertension; Left ventricular dysfunction
- Focus Pharmacodynamics
- Acronyms P3
- 01 Dec 2010 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
- 01 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Jan 2010 New trial record